Former GSK Exec Faces Charges Over Off-Label Wellbutrin Promotion

Molly Cohen

首页> 外文期刊>Washington Drug Letter >Former GSK Exec Faces Charges Over Off-Label Wellbutrin Promotion

【24h】

Former GSK Exec Faces Charges Over Off-Label Wellbutrin Promotion

机译：前葛兰素史克（GSK Exec）因非标Wellbutrin促销面临指控

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

A former GlaxoSmithKline (CSK) vice president and associate general counsel is accused of withholding documents from the FDA that apparently show off-label promotion of its antidepressantrnWellbutrin.

机译：前葛兰素史克（CSK）副总裁兼副总法律顾问被指控扣留了FDA的文件，这些文件显然表明其抗抑郁药Wellbutrin的标签外推广。

著录项

来源
《Washington Drug Letter》 |2010年第45期|p.112|共2页
作者
Molly Cohen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003–2012 [J] . Andreas Vilhelmsson, Courtney Davis, Shai Mulinari PLoS Medicine . 2016,第1期

机译：制药业标签外促销和自我监管：英国处方药业务守则权威机构2003-2012年标签外促销规定的文件分析
2. Biovail, GSK Accused of Generic Wellbutrin Delay [J] . David Belian Washington Drug Letter . 2009,第50期

机译：Biovail，葛兰素史克（GSK）被指控仿制Wellbutrin
3. GSK to sell US rights to Wellbutrin XL to Biovail [J] . Manufacturing chemist Group Manufacturing Chemist: Pharmaceutical Development, Formulation, Processing and Outsourcing . 2009,第6期

机译：葛兰素史克向美国Biovail出售Wellbutrin XL的美国版权
4. Off-label Use of Medical Devices in Cardiovascular Medicine-When the Final Decision About the Safety and Effectiveness Is Needed [C] . David Macku World Congress on Medical Physics and Biomedical Engineering . 2019

机译：在需要心血管中的医疗设备的标签使用 - 当需要对安全和有效性的最终决定时
5. Analysis of illegal off-label promotion of pharmaceuticals as a financial crime [D] . Kingston, Chad. 2014

机译：分析非法将药品非法促销为金融犯罪
6. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003–2012 [O] . Andreas Vilhelmsson, Courtney Davis, Shai Mulinari 2016

机译：制药业标签外促销和自我监管：英国处方药业务守则权威机构2003-2012年标签外促销规定的文件分析
7. Pharmaceutical Industry Off-label Promotion and Self-regulation:A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012 [O] . Vilhelmsson, Andreas, Davis, Courtney, Mulinari, Shai 2016

机译：制药业标签外促销和自我监管：英国处方药业务守则权威机构2003-2012年标签外促销规定的文件分析
8. Prescription Drugs: FDA's Oversight of the Promotion of Drugs for Off-Label Uses [R] . 2008

机译：处方药：FDa对标签外用药的促销监督

Former GSK Exec Faces Charges Over Off-Label Wellbutrin Promotion

摘要

著录项

相似文献

相关主题

期刊订阅